SecBot SecBot

AEMD

AETHLON MEDICAL INC
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. NV· CIK 0000882291 Healthcare & Medical Devices
$5.05 −0.14 (−2.70%)
Oct 23 4:00 PM ET · prev $5.19
Market cap
$8.3M
Nano cap
Median target
🔒 Subscribers only
1 year
−81.3%
from $26.95 · Oct 24
30 days
−25.4%
from $6.77
52-week range
$1.43–28.75
−82% from high · low Sep 16
Avg volume 20D
70.1K
Oct 22 spike 211.2K
Short interest
75.4K
≈4.7% of shares · +0.8%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
15
analyzed by SecBot
SecBot read MIXED 9 reports · 90 days
Balance 3 bearish · 2 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 8/9 ·Next Earnings date, Nov 10, 2026
Strongest BEARISH Aethlon Medical held its 2026 Annual Meeting on October 1, 2026, with stockholders approving all 10…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest +0.8% to 75.4K shares. 1.0 days to cover, ≈4.7% of shares.

  • TrendUPTREND

    20% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCTRIM10,189$8.4K
UBS Group AGDOUBLED8,876$7.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Aug 2025

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Aug 14, 2025HC Wainwright & Co.
REITERATE
REITERATENeutral
Mar 10, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy
Feb 19, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy
Jan 30, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy
Nov 15, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Jun 24, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 10, 2026
Earnings date
🔒 Fresh data — subscribers only
Recent
Sep 18, 2026
Press release
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)
NEW YORK, Sept. 18, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has…
Aug 13, 2026
Earnings
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
Conference Call Today at 4:30 p.m. ET SAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a…
Aug 13, 2026
Earnings date
AEMD Q1 2027 Earnings Scheduled — 2026-08-13
Aug 11, 2026
Earnings date
AEMD Q1 2027 Earnings Scheduled — 2026-08-11
Aug 5, 2026
Earnings
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat…

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 8, 2026
FRAKES JAMES B
CFO/CEO
AWARD42,000 sh
Oct 8, 2026
LAROSA STEVEN P
Chief Medical Officer
AWARD42,000 sh
Sep 30, 2026
Shah Chetan
Director
TAX W/H$2.8K
Sep 30, 2026
Gikakis Nicolas
Director
TAX W/H$2.8K
Sep 30, 2026
BROENNIMAN EDWARD G
Director
TAX W/H$1.4K
Jun 30, 2026
Gikakis Nicolas
Director
TAX W/H$1.8K
Jun 30, 2026
BROENNIMAN EDWARD G
Director
TAX W/H$894.62
Jun 30, 2026
Shah Chetan
Director
TAX W/H$1.8K

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
75,446
shares short
+0.8%
vs prior settlement
1.0
days to cover
≈4.7%
of shares outstanding
Trading halts
Aug 3, 2026News PendingNot resumed
Aug 3, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
Jane Street Group, LLC disclosed a passive 5.0% stake in Aethlon Medical Inc (AEMD) via a Schedule 13G filing…
SC 13G — Impact 3/10
Oct 8, 2026 Insider
FRAKES JAMES B was granted 42,000 shares
CFO/CEO
Oct 8, 2026 Insider
LAROSA STEVEN P was granted 42,000 shares
Chief Medical Officer
Oct 1, 2026 SEC
Aethlon Medical held its 2026 Annual Meeting on October 1, 2026, with stockholders approving all 10 proposals…
8-K — Impact 7/10
Sep 30, 2026 Insider
Shah Chetan surrendered for taxes 436 shares
Director @ $6.52 ($2.8K)
Sep 18, 2026 Other
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)
NEW YORK, Sept. 18, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
Sep 17, 2026 SEC
Aethlon Medical (AEMD) filed the definitive merger agreement to acquire North Immunology, Inc. in a reverse-merger…
425 — Impact 8/10
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
10,189 shares ($8.4K)

SecBot reports

15 filings · 2 bullish · 8 bearish · 5 neutral
All AEMD filing & press-release reports (15)